HEXOVAC: Exosome-deived quasi-enveloped virus particles as candidate for novel hepatitis A and E vaccines.
Show side menu

Starting date:
21/06/2019
End date:
20/06/2022
Programme:
Animal Health
Principal investigator:
Financing entities:
The present proposal addresses four main objectives:
|